Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,068 | 500 | 0 | 0 | 0 |
| Cost of Goods | 112 | N/A | N/A | N/A | N/A |
| Gross Profit | 1,956 | 500 | N/A | N/A | N/A |
| Operating Expenses | 23,816 | 15,840 | 13,192 | 10,226 | 17,978 |
| Operating Income | -21,748 | -15,340 | -13,192 | -10,226 | -17,978 |
| Other Income | 2,620 | 2,824 | 2,900 | 3,058 | 3,112 |
| Pre-tax Income | -19,128 | -12,516 | -10,292 | -7,168 | -14,866 |
| Net Income Continuous | -19,128 | -12,516 | -10,292 | -7,168 | -14,866 |
| Net Income | $-19,128 | $-12,516 | $-10,292 | $-7,168 | $-14,866 |
| EPS Basic Total Ops | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 |
| EPS Basic Continuous Ops | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 |
| EPS Diluted Total Ops | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 |
| EPS Diluted Continuous Ops | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.13 | -0.11 | N/A | N/A |
| EBITDA(a) | $-23,553 | $-17,226 | $-15,161 | $-11,941 | $-19,517 |